These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21826705)

  • 1. ERα17p, an ERα P295 -T311 fragment, modifies the migration of breast cancer cells, through actin cytoskeleton rearrangements.
    Kampa M; Pelekanou V; Gallo D; Notas G; Troullinaki M; Pediaditakis I; Charalampopoulos I; Jacquot Y; Leclercq G; Castanas E
    J Cell Biochem; 2011 Dec; 112(12):3786-96. PubMed ID: 21826705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole transcriptome analysis of the ERα synthetic fragment P295-T311 (ERα17p) identifies specific ERα-isoform (ERα, ERα36)-dependent and -independent actions in breast cancer cells.
    Notas G; Kampa M; Pelekanou V; Troullinaki M; Jacquot Y; Leclercq G; Castanas E
    Mol Oncol; 2013 Jun; 7(3):595-610. PubMed ID: 23474223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trophic effect in MCF-7 cells of ERalpha17p, a peptide corresponding to a platform regulatory motif of the estrogen receptor alpha--underlying mechanisms.
    Gallo D; Haddad I; Duvillier H; Jacquemotte F; Laïos I; Laurent G; Jacquot Y; Vinh J; Leclercq G
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):138-49. PubMed ID: 18262408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The estrogen receptor alpha-derived peptide ERα17p (P(295)-T(311)) exerts pro-apoptotic actions in breast cancer cells in vitro and in vivo, independently from their ERα status.
    Pelekanou V; Kampa M; Gallo D; Notas G; Troullinaki M; Duvillier H; Jacquot Y; Stathopoulos EN; Castanas E; Leclercq G
    Mol Oncol; 2011 Feb; 5(1):36-47. PubMed ID: 21163714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
    Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibronectin and type IV collagen activate ERalpha AF-1 by c-Src pathway: effect on breast cancer cell motility.
    Sisci D; Aquila S; Middea E; Gentile M; Maggiolini M; Mastroianni F; Montanaro D; Andò S
    Oncogene; 2004 Nov; 23(55):8920-30. PubMed ID: 15467744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inherent role of integrin-linked kinase-estrogen receptor alpha interaction in cell migration.
    Acconcia F; Manavathi B; Mascarenhas J; Talukder AH; Mills G; Kumar R
    Cancer Res; 2006 Nov; 66(22):11030-8. PubMed ID: 17108142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of estrogen receptor alpha and histone deacetylase 6 causes rapid deacetylation of tubulin in breast cancer cells.
    Azuma K; Urano T; Horie-Inoue K; Hayashi S; Sakai R; Ouchi Y; Inoue S
    Cancer Res; 2009 Apr; 69(7):2935-40. PubMed ID: 19318565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
    Surmacz E; Bartucci M
    J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentagalloylglucose inhibits estrogen receptor alpha by lysosome-dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF-7 cells.
    Hua KT; Way TD; Lin JK
    Mol Carcinog; 2006 Aug; 45(8):551-60. PubMed ID: 16637063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
    Weitsman GE; Weebadda W; Ung K; Murphy LC
    Breast Cancer Res Treat; 2009 Nov; 118(2):269-79. PubMed ID: 18941890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells.
    Le Dily F; Métivier R; Guéguen MM; Le Péron C; Flouriot G; Tas P; Pakdel F
    Breast Cancer Res Treat; 2008 Jul; 110(1):69-83. PubMed ID: 17674191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines.
    Mohamood AS; Gyles P; Balan KV; Hollis VW; Eckberg WR; Asseffa A; Han Z; Wyche JH; Anderson WA
    J Submicrosc Cytol Pathol; 1997 Jan; 29(1):1-17. PubMed ID: 9066137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo.
    Van Themsche C; Parent S; Leblanc V; Descôteaux C; Simard AM; Bérubé G; Asselin E
    Endocr Relat Cancer; 2009 Dec; 16(4):1185-95. PubMed ID: 19661132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells.
    Vijayanathan V; Venkiteswaran S; Nair SK; Verma A; Thomas TJ; Zhu BT; Thomas T
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2038-48. PubMed ID: 16609013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel antiestrogen agent Shikonin inhibits estrogen-dependent gene transcription in human breast cancer cells.
    Yao Y; Zhou Q
    Breast Cancer Res Treat; 2010 May; 121(1):233-40. PubMed ID: 19760501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.